Genie Health closes a US$3 mil seed round to grow its health intelligence platform
- ID
- 37737
- Status
- summarized
- Published
- 21 Oct 2026, 12:07 PM
- Fetched
- 21 Oct 2026, 12:11 PM
- Provider
- Digital News Asia
- Category
- malaysia-tech
- Original URL
- https://www.digitalnewsasia.com/startups/genie-health-closes-us3-mil-seed-round-grow-its-health-intelligence-platform
- Source URL
- https://www.digitalnewsasia.com/rss.xml
Summary
- Score
- 4.0
- Created
- 21 Oct 2026, 12:11 PM
- Tags
- Audience
- saas_startup_foundersai_agent_users
What happened
Genie Health, described as a Singapore-based startup, raised a US$3 million (RM12.2 million) seed round led by the Nadathur Family Office, with participation from Liminal, a Founders' Studio backed by Temasek, plus two healthcare investors; Anand Nadathur joins the board. The company runs two products: Genie, a consumer health app that turns a member's health information into personalised insights, and Genie SmartCare, a clinic intelligence platform using agentic AI for patient engagement. Proceeds are earmarked for deepening AI capabilities, driving SmartCare adoption among clinics, and hiring product, engineering and healthcare staff in Singapore.
Why it matters
The article gives almost no product, pricing, or technical detail, so there is nothing here a builder must change this week. The one usable signal is the stated spending plan: a US$3M seed for a two-sided health platform is going to clinic adoption and platform depth rather than model R&D, which is the shape investors are currently funding in SEA vertical AI. Treat it as a comparable for your own pitch or hiring plans, not as a technology update.
Discussion angle
Agentic AI in a regulated vertical like clinic workflows: what does 'patient engagement' actually require — integrations with clinic systems, compliance, or the model itself — and does a US$3M seed get you far enough to prove it before the next raise?